Literature DB >> 26856240

High rate of missed HIV infections in individuals with indeterminate or negative HIV western blots based on current HIV testing algorithm in China.

Man-Qing Liu1, Ze-Rong Zhu1, Wen-Hua Kong1, Li Tang1, Jin-Song Peng1, Xia Wang1, Jun Xu1, Robert F Schilling2, Thomas Cai3, Wang Zhou1.   

Abstract

It remains unclear if China's current HIV antibody testing algorithm misses a substantial number of HIV infected individuals. Of 196 specimens with indeterminate or negative results on HIV western blot (WB) retrospectively examined by HIV-1 nucleic acid test (NAT), 67.57% (75/111) of indeterminate WB samples, and 16.47% (14/85) of negative WB samples were identified as NAT positive. HIV-1 loads in negative WB samples were significantly higher than those in indeterminate WB samples. Notably, 86.67% (13/15) of samples with negative WB and double positive immunoassay results were NAT positive. The rate of HIV-1 infections missed by China's current HIV testing algorithm is unacceptably high. Thus, China should consider using NAT or integrating fourth generation ELISA into current only antibodies-based HIV confirmation. J. Med. Virol. 88:1462-1466, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  China; HIV-1 nucleic acid test (NAT); enzyme-linked immunosorbent assays (ELISA); western blot (WB)

Mesh:

Substances:

Year:  2016        PMID: 26856240     DOI: 10.1002/jmv.24490

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

1.  Evaluation of the Bio-Rad Geenius HIV 1/2 Assay as Part of a Confirmatory HIV Testing Strategy for Quebec, Canada: Comparison with Western Blot and Inno-Lia Assays.

Authors:  Bouchra Serhir; Céline Desjardins; Florence Doualla-Bell; Marc Simard; Cécile Tremblay; Jean Longtin
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

2.  HIV and other STIs self-testing to reduce risk compensation among men who have sex with men who use oral pre-exposure prophylaxis in China: protocol for a randomised waitlist-controlled trial.

Authors:  Jing Zhang; Xiaojie Huang; Yaokai Chen; Hui Wang; Yonghui Zhang; Hongyi Wang; Zhu Mei; Yueru Jia; ZhenXing Chu; Qing-Hai Hu; Xiaoqing He; Lukun Zhang; Zhili Hu; Rantong Bao; Shangcao Li; Haibo Ding; Yongjun Jiang; Wenqing Geng; Weiming Tang; Junjie Xu
Journal:  BMJ Open       Date:  2020-07-19       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.